期刊文献+

他汀类药物临床研究进展 被引量:40

Clinical Trials Progress in Statin Therapy
在线阅读 下载PDF
导出
摘要 随着他汀类药物在临床上的广泛应用,其降脂作用和各种降脂外的疗效在很大程度上减少了心血管事件发生的风险。同时,人们也对他汀类药物和心血管事件在循证医学的关系上产生了浓厚的兴趣,一系列大规模的临床试验正试图评价他汀类药物对各种心血管事件的切实疗效,现就此方面作一综述。 The treatment of cardiovascular diseases with statins predominantly reduces cardiovascular risk in a wide variety of patients. Meanwhile,there is increasing interest in the relationship between statins and cardiovascular events in evidence-based level. Serial large scale clinic trials are on going to evaluate the real therapeutic effect of statins on cardiovascular events.
出处 《心血管病学进展》 CAS 2006年第1期79-82,共4页 Advances in Cardiovascular Diseases
关键词 他汀类药物 心血管疾病 statins cardiovascular disease
  • 相关文献

参考文献15

  • 1Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes:a randomised placebo-controlled trial[J]. Lancet ,2003,361:2005-2016.
  • 2Sever PS,Dahlof B, Poulter NR,et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA) : a multicenter randomized controlled trial[J]. Lancet,2003,361:1149-1158.
  • 3Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention[J]. Circulation ,2003,107:363-369.
  • 4Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events[J]. N Engl J Med,2002,347:1557-1565.
  • 5Ridker PM, Buring JE, Cook NR, et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14,719 initially healthy Americau women[J]. Circulation,2003,107:391-397.
  • 6Ridker PM, Rifai N, Pfeffer M, et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein[ J]. Circulation, 1999,100:230-235.
  • 7Albert MA, Danielson E, Rifai N, et al. Effect of statin therapy on C-reactive protein levels. The Pravastatin Inflammation/CRP Evaluation(PRINCE) :a randomized trial and cohort study[J]. JAMA,2001,286:64-70.
  • 8Strandberg TE,Vanhanen H,Tikkanen M J, Association between change in C-reactive protein and serum lipids during statin treatment[J]. Ann Med,2000,32 :579-583.
  • 9van Wissert S, Trip MD, Smilde TJ, et al. Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy [J]. Atherosclerosis ,2002,165:361-366.
  • 10Ridker PM ,Rifai N ,Pfeffer MA ,et al. Inflammation ,pravastatin ,and the risk of coronary events after myocardial infarction in patients with average cholesterol levels[J]. Circulation, 1998,98:839-844.

同被引文献243

引证文献40

二级引证文献157

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部